Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

P. Kumar Rao; Christopher Barker; Daniel G. Coit; Richard W. Joseph; Miguel Materin; Ramesh Rengan; Jeffrey Sosman; John A. Thompson; Mark R. Albertini; Genevieve Boland; William E. Carson; Carlo Contreras; Gregory A. Daniels; Dominick DiMaio; Alison Durham; Ryan C. Fields; Martin D. Fleming; Anjela Galan; Brian Gastman; Kenneth Grossman; Valerie Guild; Douglas Johnson; Giorgos Karakousis; Julie R. Lange; Kim Margolin; Sameer Nath; Anthony J. Olszanski; Patrick A. Ott; Merrick I. Ross; April K. Salama; Joseph Skitzki; Susan M. Swetter; Evan Wuthrick; Nicole R. McMillian; Anita Engh

doi:10.6004/jnccn.2020.0006

Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

P. Kumar Rao
, Christopher Barker
, Daniel G. Coit
, Richard W. Joseph
, Miguel Materin
, Ramesh Rengan
, Jeffrey Sosman
, John A. Thompson
, Mark R. Albertini
, Genevieve Boland
, William E. Carson
, Carlo Contreras
, Gregory A. Daniels
, Dominick DiMaio
, Alison Durham
, Ryan C. Fields
, Martin D. Fleming
, Anjela Galan
, Brian Gastman
, Kenneth Grossman

Valerie Guild, Douglas Johnson, Giorgos Karakousis, Julie R. Lange, Kim Margolin, Sameer Nath, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, April K. Salama, Joseph Skitzki, Susan M. Swetter, Evan Wuthrick, Nicole R. McMillian, Anita Engh

Washington University St. Louis
Memorial Sloan-Kettering Cancer Center
Mayo Clinic
Duke University
Seattle Cancer Care Alliance
Northwestern University
University of Wisconsin-Madison
Massachusetts General Hospital Cancer Center
Ohio State University
University of Alabama at Birmingham
University of California at San Diego
University of Nebraska Medical Center
University of Michigan, Ann Arbor
University of Tennessee Health Science Center
Yale University
Case Western Reserve University
University of Utah
AIM
Vanderbilt University
University of Pennsylvania
Johns Hopkins University
City of Hope National Medical Center
University of Colorado Cancer Center
Dana-Farber/Brigham and Women's Cancer Center
University of Texas MD Anderson Cancer Center
Roswell Park Cancer Institute
Stanford University
University of South Florida
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

Original language	English
Pages (from-to)	121-131
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	18
Issue number	2
DOIs	https://doi.org/10.6004/jnccn.2020.0006
State	Published - 2020

Keywords

Antineoplastic Combined Chemotherapy Protocols/pharmacology
Biomarkers, Tumor/analysis
Bone Marrow/pathology
Disease-Free Survival
Drug Resistance, Neoplasm/genetics
Hematopoietic Stem Cell Transplantation/methods
Humans
Immunophenotyping
Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis
Lymph Nodes/cytology
Lymphocytes/pathology
Medical Oncology/methods
Mutation
Neoplasm Recurrence, Local/epidemiology
Neoplasm Staging
Organizations, Nonprofit/standards
Prognosis
Remission Induction/methods
Transplantation, Homologous/standards
United States/epidemiology

Access to Document

10.6004/jnccn.2020.0006

Cite this

Kumar Rao, P., Barker, C., Coit, D. G., Joseph, R. W., Materin, M., Rengan, R., Sosman, J., Thompson, J. A., Albertini, M. R., Boland, G., Carson, W. E., Contreras, C., Daniels, G. A., DiMaio, D., Durham, A., Fields, R. C., Fleming, M. D., Galan, A., Gastman, B., ... Engh, A. (2020). Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 18(2), 121-131. https://doi.org/10.6004/jnccn.2020.0006

@article{28e8722ca1714f04a9a3d1ceddfb6015,

title = "Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.",

keywords = "Antineoplastic Combined Chemotherapy Protocols/pharmacology, Biomarkers, Tumor/analysis, Bone Marrow/pathology, Disease-Free Survival, Drug Resistance, Neoplasm/genetics, Hematopoietic Stem Cell Transplantation/methods, Humans, Immunophenotyping, Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis, Lymph Nodes/cytology, Lymphocytes/pathology, Medical Oncology/methods, Mutation, Neoplasm Recurrence, Local/epidemiology, Neoplasm Staging, Organizations, Nonprofit/standards, Prognosis, Remission Induction/methods, Transplantation, Homologous/standards, United States/epidemiology",

author = "\{Kumar Rao\}, P. and Christopher Barker and Coit, \{Daniel G.\} and Joseph, \{Richard W.\} and Miguel Materin and Ramesh Rengan and Jeffrey Sosman and Thompson, \{John A.\} and Albertini, \{Mark R.\} and Genevieve Boland and Carson, \{William E.\} and Carlo Contreras and Daniels, \{Gregory A.\} and Dominick DiMaio and Alison Durham and Fields, \{Ryan C.\} and Fleming, \{Martin D.\} and Anjela Galan and Brian Gastman and Kenneth Grossman and Valerie Guild and Douglas Johnson and Giorgos Karakousis and Lange, \{Julie R.\} and Kim Margolin and Sameer Nath and Olszanski, \{Anthony J.\} and Ott, \{Patrick A.\} and Ross, \{Merrick I.\} and Salama, \{April K.\} and Joseph Skitzki and Swetter, \{Susan M.\} and Evan Wuthrick and McMillian, \{Nicole R.\} and Anita Engh",

year = "2020",

doi = "10.6004/jnccn.2020.0006",

language = "English",

volume = "18",

pages = "121--131",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "2",

}

Kumar Rao, P, Barker, C, Coit, DG, Joseph, RW, Materin, M, Rengan, R, Sosman, J, Thompson, JA, Albertini, MR, Boland, G, Carson, WE, Contreras, C, Daniels, GA, DiMaio, D, Durham, A, Fields, RC, Fleming, MD, Galan, A, Gastman, B, Grossman, K, Guild, V, Johnson, D, Karakousis, G, Lange, JR, Margolin, K, Nath, S, Olszanski, AJ, Ott, PA, Ross, MI, Salama, AK, Skitzki, J, Swetter, SM, Wuthrick, E, McMillian, NR & Engh, A 2020, 'Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 18, no. 2, pp. 121-131. https://doi.org/10.6004/jnccn.2020.0006

TY - JOUR

T1 - Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

AU - Kumar Rao, P.

AU - Barker, Christopher

AU - Coit, Daniel G.

AU - Joseph, Richard W.

AU - Materin, Miguel

AU - Rengan, Ramesh

AU - Sosman, Jeffrey

AU - Thompson, John A.

AU - Albertini, Mark R.

AU - Boland, Genevieve

AU - Carson, William E.

AU - Contreras, Carlo

AU - Daniels, Gregory A.

AU - DiMaio, Dominick

AU - Durham, Alison

AU - Fields, Ryan C.

AU - Fleming, Martin D.

AU - Galan, Anjela

AU - Gastman, Brian

AU - Grossman, Kenneth

AU - Guild, Valerie

AU - Johnson, Douglas

AU - Karakousis, Giorgos

AU - Lange, Julie R.

AU - Margolin, Kim

AU - Nath, Sameer

AU - Olszanski, Anthony J.

AU - Ott, Patrick A.

AU - Ross, Merrick I.

AU - Salama, April K.

AU - Skitzki, Joseph

AU - Swetter, Susan M.

AU - Wuthrick, Evan

AU - McMillian, Nicole R.

AU - Engh, Anita

PY - 2020

Y1 - 2020

N2 - The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

AB - The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

KW - Antineoplastic Combined Chemotherapy Protocols/pharmacology

KW - Biomarkers, Tumor/analysis

KW - Bone Marrow/pathology

KW - Disease-Free Survival

KW - Drug Resistance, Neoplasm/genetics

KW - Hematopoietic Stem Cell Transplantation/methods

KW - Humans

KW - Immunophenotyping

KW - Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis

KW - Lymph Nodes/cytology

KW - Lymphocytes/pathology

KW - Medical Oncology/methods

KW - Mutation

KW - Neoplasm Recurrence, Local/epidemiology

KW - Neoplasm Staging

KW - Organizations, Nonprofit/standards

KW - Prognosis

KW - Remission Induction/methods

KW - Transplantation, Homologous/standards

KW - United States/epidemiology

UR - https://www.scopus.com/pages/publications/85082319200

U2 - 10.6004/jnccn.2020.0006

DO - 10.6004/jnccn.2020.0006

M3 - Article

C2 - 32023533

AN - SCOPUS:85082319200

SN - 1540-1405

VL - 18

SP - 121

EP - 131

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 2

ER -

Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this